Provides high intensity energy delivery in a short time, allowing the muscles to work
Participants will be randomized (1:1) to receive a GLP-1RA or a dipeptidyl peptidase-4 inhibitor (DPP-4i) for 24 weeks as part of routine glucose-lowering therapy optimization
ensure sufficient protein (often 1.2-1.6 g/kg body weight/day, sometimes more depending on the individual and activity)
The difference between a clinical setting and a wellness lounge shows up in patient safety, formulation, and what happens when something goes wrong
Compounded formulations through PlexusDx licensed pharmacies offer cost-effective access to proven active ingredients under qualified medical supervision, avoiding the patch-marketing confusion that may delay appropriate treatment
You can book an online and in-person appointment with specialist doctors through Marham's website, Android app, iOS app, and by calling 03111222398